Up 246%: Is This Small-Cap Biotech Stock Still a Buy?

Affimed struck a game-changing deal with Roche yesterday, causing its shares to sky-rocket."Up 246%: Is This Small-Cap Biotech Stock Still a Buy?" via FOX BIZ https://ift.tt/2BYyRd1